Abstract
Network analysis allows investigators to explore the many facets of brain networks, particularly the proliferation of disease, using graph theory to model the disease movement. One of the hypotheses behind the disruption in brain networks in Alzheimer’s disease (AD) is the abnormal accumulation of beta-amyloid plaques and tau protein tangles. In this study, the potential use of percolation centrality to study the movement of beta-amyloids, as a feature of given PET image-based networks, is studied. The PET image-based network construction is possible using a public access database - Alzheimer’s Disease Neuroimaging Initiative, which provided 551 scans. For each image, the Julich atlas provides 121 regions of interest, which are the network nodes. Besides, the influential nodes for each scan are calculated using the collective influence algorithm. Analysis of variance (p<0.05) yields the region of interest GM Superior parietal lobule 7A L, for which percolation centrality is significant irrespective of the tracer type. Pairwise variance analysis between the clinical groups provides five and twelve candidates for AV45 and PiB. Multivariate linear regression between the percolation centrality values for nodes and psychometric assessment scores reveals Mini-Mental State Examination is a reliable metric. Finally, a ranking of the regions of interest is made based on the collective influence algorithm to indicate the anatomical areas strongly influencing the beta-amyloid network. Through this study, it is possible to use percolation centrality values to indicate the regions of interest that reflect the disease’s spread.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Data usage and analysis for this study is enabled by the Alzheimer's Disease Neuroimaging Initiative - National Institutes of Health Grant U01 AG024904, DOD ADNI, Department of Defense award number W81XWH-12-2-0012
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Informed consent from the patients is obtained prior to the assessment carried out by ADNI study team (See ADNI website for details), and this study is a secondary data analysis of the ADNI data collection, which aims at providing a simplified metric to an already diagnosed patient.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Abbreviations
- AD
- Alzheimer’s Disease
- ANOVA
- Analysis of Variance
- AV45
- Florbetapir (18F-AV-45)
- CI
- Collective Influence
- CN
- Cognitively Normal
- CSF
- Cerebrospinal Fluid
- EEG
- Electroencephalography
- FAB
- Frontal Assessment Battery
- FDG
- Fluorodeoxyglucose (18F-FDG)
- fMRI
- functional Magnetic Resonance Imaging
- FSL
- FMRIB Software Library
- GNU
- GNU’s Not Unix
- PCv
- Percolation Centrality Value PET, Positron Emission tomography
- PiB
- Pittsburgh compound B (11C-PIB)
- RMSE
- Root Mean Square Error
- MCI
- Mild Cognitive Impairment
- MEG
- Magnetoencephalography
- MLR
- Multivariate Linear Regression
- MMSE
- Mini-Mental State Examination
- NPIQ
- Neuropsychiatric Inventory Questionnaire
- OMST
- Orthogonal Minimum Spanning Tree
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.